Carnegie Investment Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.1M | Sell |
|
|||||
|
2025
Q2 | $20M | Buy |
|
|||||
|
2025
Q1 | $17.4M | Buy |
|
|||||
|
2024
Q4 | $17.1M | Sell |
|
|||||
|
2024
Q3 | $25.4M | Sell |
|
|||||
|
2024
Q2 | $30.6M | Buy |
|
|||||
|
2024
Q1 | $27.3M | Buy |
|
|||||
|
2023
Q4 | $21.3M | Buy |
|
|||||
|
2023
Q3 | $18.2M | Buy |
|
|||||
|
2023
Q2 | $14.6M | Buy |
|
|||||
|
2023
Q1 | $14.2M | Buy |
|
|||||
|
2022
Q4 | $11.3M | Buy |
|
|||||
|
2022
Q3 | $6.04M | Sell |
|
|||||
|
2022
Q2 | $6.85M | Sell |
|
|||||
|
2022
Q1 | $7.03M | Sell |
|
|||||
|
2021
Q4 | $7.32M | Sell |
|
|||||
|
2021
Q3 | $6.39M | Buy |
|
|||||
|
2021
Q2 | $5.54M | Sell |
|
|||||
|
2021
Q1 | $4.53M | Buy |
|
|||||
|
2020
Q4 | $4.67M | Sell |
|
|||||
|
2020
Q3 | $4.68M | Sell |
|
|||||
|
2020
Q2 | $4.46M | Sell |
|
|||||
|
2020
Q1 | $4.14M | Sell |
|
|||||
|
2019
Q4 | $4.05M | Buy |
|
|||||
|
2019
Q3 | $3.42M | Sell |
|
|||||
|
2019
Q2 | $3.76M | Sell |
|
|||||
|
2019
Q1 | $4.33M | Sell |
|
|||||
|
2018
Q4 | $4.08M | Sell |
|
|||||
|
2018
Q3 | $4.84M | Buy |
|
|||||
|
2018
Q2 | $5.01M | Sell |
|
|||||
|
2018
Q1 | $5.31M | Sell |
|
|||||
|
2017
Q4 | $5.67M | Sell |
|
|||||
|
2017
Q3 | $5.86M | Sell |
|
|||||
|
2017
Q2 | $5.2M | Sell |
|
|||||
|
2017
Q1 | $5.18M | Sell |
|
|||||
|
2016
Q4 | $5.79M | Sell |
|
|||||
|
2016
Q3 | $6.67M | Buy |
|
|||||
|
2016
Q2 | $8.84M | Sell |
|
|||||
|
2016
Q1 | $8.6M | Buy |
|
|||||
|
2015
Q4 | $8.71M | Sell |
|
|||||
|
2015
Q3 | $8.76M | Buy |
|
|||||
|
2015
Q2 | $8.23M | Sell |
|
|||||
|
2015
Q1 | $8.43M | Buy |
|
|||||
|
2014
Q4 | $6.49M | Buy |
|
|||||
|
2014
Q3 | $6.68M | Sell |
|
|||||
|
2014
Q2 | $6.52M | Buy |
|
|||||
|
2014
Q1 | $6.29M | Sell |
|
|||||
|
2013
Q4 | $5.3M | Buy |
|
|||||
|
2013
Q3 | $4.1M | Buy |
|
|||||
|
2013
Q2 | $3.51M | Buy |
|